Background: High-quality estimates of health care costs are required to understand the
burden of illness and to inform economic models. We estimated the costs associated with …

Background: Colonization and marginalization have affected the risk for and experience of
hepatitis C virus (HCV) infection for First Nations people in Canada. In partnership with the …

BACKGROUND: Chronic infection with hepatitis C virus (HCV) is a major cause of cirrhosis,
hepatocellular carcinoma and liver transplantation. OBJECTIVE: To estimate the burden of …

Abstract Objectives Chronic hepatitis C (CHC) infection affects more than 70 million people
worldwide and imposes considerable health and economic burdens on patients and society …

Objectives Incidence of hepatitis C viral infection (HCV) is increasing in China and HCV
represents considerable disease burden to the country. As there is no published data on …

The aim of this work was to estimate and describe the Medicare beneficiaries diagnosed
with hepatitis C virus (HCV) in 2009, incremental annual costs by disease stage, incremental …

BACKGROUND: Disease-specific estimates of medical costs are important for health policy
decision making. OBJECTIVE: To identify predictors of health care costs associated with …

There are approximately 100 drugs in development to treat hepatitis C. Over the next
decade, a number of new therapies will become available. A good understanding of the cost …

Hepatitis C virus (HCV) infection increases total healthcare costs but the effect of the severity
of liver disease associated with chronic hepatitis C (CHC) on healthcare costs has not been …

Results Of the 20,662 patients who met all inclusion criteria, mean age was 49 years; 61%
were male. Adjusted all-cause costs were $20,961 per HCV patient, compared with $5451 …